A new path with Sanofi Vaccines
- July 22, 2022
Mersaco is delighted to announce its new partnership with Sanofi, by extending its current portfolio with the distribution of the Sanofi Vaccines, effective June 1st, 2022.
“We look forward to this new step with Sanofi after many successful years of business relationship. Our aim is to uphold high levels of quality and safety measures in the distribution of the Sanofi Influenza and Pediatrics vaccines product range across all pharmacies and hospitals in Lebanon'', stated Walid Mroueh, Mersaco Chief Executive Officer.
“We trust that with this new agreement, Mersaco will contribute to achieving our goals by securing life-protecting vaccines to the Lebanese community despite all challenges” announced Marwan Sherif, General Manager Levant and Iraq at Sanofi Vaccines. He added “This new step will ensure that Sanofi continues on its mission of securing access to innovative vaccines and contribute to the increase of vaccination coverage rates so that no one suffers or dies from a vaccine-preventable disease”.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Mersaco is a leading healthcare distributor in Lebanon and has been providing pharmaceutical and cosmetic products since 1959. With 400 employees, Mersaco goes beyond care to better serve our community and partners.